ARCA biopharma, FDA reach agreement on test for heart failure drug

ARCA biopharma, FDA reach agreement on test for heart failure drug

WESTMINSTER -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases,... Read More

Tuesday February 26, 2019 0 comments Tags: Westminster, ARCA biopharma, Michael Bristow, Gencaro